FoxO3 Controls Autophagy in Skeletal Muscle In Vivo  by Mammucari, Cristina et al.
Cell Metabolism
ArticleFoxO3 Controls Autophagy
in Skeletal Muscle In Vivo
Cristina Mammucari,1,2 Giulia Milan,1,3 Vanina Romanello,1,3 Eva Masiero,1 Ruediger Rudolf,1,4
Paola Del Piccolo,1 Steven J. Burden,5 Raffaella Di Lisi,1 Claudia Sandri,1,3 Jinghui Zhao,6 Alfred L. Goldberg,6
Stefano Schiaffino,1,2,7 and Marco Sandri1,2,3,*
1Venetian Institute of Molecular Medicine, 35129 Padova, Italy
2Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy
3Dulbecco Telethon Institute, 35129 Padova, Italy
4Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe, 76021 Karlsruhe, Germany
5Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA
6Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
7Institute of Neuroscience, Consiglio Nazionale delle Ricerche, 35121 Padova, Italy
*Correspondence: marco.sandri@unipd.it
DOI 10.1016/j.cmet.2007.11.001SUMMARY
Autophagy allows cell survival during starvation
through the bulk degradation of proteins and
organelles by lysosomal enzymes. However,
the mechanisms responsible for the induction
and regulation of the autophagy program are
poorly understood. Here we show that the
FoxO3 transcription factor,whichplays acritical
role in muscle atrophy, is necessary and suffi-
cient for the induction of autophagy in skeletal
muscle in vivo. Akt/PKB activation blocks
FoxO3 activation and autophagy, and this effect
is not prevented by rapamycin. FoxO3 controls
the transcription of autophagy-related genes,
including LC3 and Bnip3, and Bnip3 appears
to mediate the effect of FoxO3 on autophagy.
This effect is not prevented by proteasome in-
hibitors. Thus, FoxO3 controls the two major
systems of protein breakdown in skeletal mus-
cle, the ubiquitin-proteasomal and autophagic/
lysosomal pathways, independently. These find-
ings point to FoxO3 and Bnip3 as potential
therapeutic targets in muscle wasting disorders
and other degenerative and neoplastic dis-
eases in which autophagy is involved.
INTRODUCTION
Protein degradation in skeletal muscle cells is essentially
mediated by the activity of two highly conserved path-
ways, the ubiquitin-proteasomal pathway and the auto-
phagic/lysosomal pathway. In the first, target proteins
are conjugated to multiple ubiquitin moieties and ubiqui-
tin-tagged proteins are degraded within the proteasome
complex (Lecker et al., 2006). In the second, portions of
cytoplasm and cell organelles are sequestered into vacu-
oles, called autophagosomes, with subsequent fusion of458 Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevieautophagosomes with lysosomes and digestion of the
content of the vacuoles by lysosomal hydrolases (Lum
et al., 2005). The molecular components of these path-
ways have been extensively characterized, but the regula-
tory networks that control their function are still incom-
pletely defined.
The ubiquitin-proteasomal pathway is constitutively op-
erative in normal skeletal muscle and is responsible for the
turnover of most soluble and myofibrillar muscle proteins
(Lecker et al., 2006). The activity of this pathway is mark-
edly increased in atrophying muscle due to transcriptional
activation of ubiquitin; several proteasomal subunit genes;
and two muscle-specific ubiquitin ligases, atrogin-1/
MAFbx andMuRF1, which are induced severalfold during
early stages of muscle atrophy (Gomes et al., 2001). Im-
portantly, the rate of muscle atrophy is markedly reduced
by targeted inactivation of these genes (Bodine et al.,
2001a). Two major signaling pathways appear to control
the activation of muscle ubiquitin ligases. One is mediated
by the forkhead box O (FoxO) transcription factors, which
are normally phosphorylated and inactivated by Akt/PKB
but translocate to the nucleus and induce the transcription
of both atrogin-1 andMuRF1 in the absence of Akt repres-
sion (Sandri et al., 2004; Stitt et al., 2004). The second reg-
ulatory pathway involves the transcription factor NF-kB,
which is known to mediate the effect of the cytokine
TNF-a in the inflammatory response and which in turn is
able to induce the activation of MuRF1 (Cai et al., 2004).
Autophagy is also constitutively active in skeletal mus-
cle, as shown by the accumulation of autophagosomes
seen in human myopathies caused by genetic deficiency
of lysosomal proteins, e.g., Pompe’s and Danon’s dis-
eases, or by pharmacological inhibition of lysosomal func-
tion, as in chloroquine myopathy (Shintani and Klionsky,
2004). Electron microscopic studies have previously
shown that autophagy is activated in denervation atrophy
(Schiaffino and Hanzlikova, 1972b) and that the lysosomal
proteolytic system is stimulated in different conditions
leading tomuscle atrophy (Bechet et al., 2005). Autophagy
is also induced in skeletal muscle in the immediate post-
natal period, when glycogen-filled autophagosomes arer Inc.
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FoxO3 in Autophagyespecially abundant (Schiaffino and Hanzlikova, 1972a).
The crucial role of autophagy in newborns is demon-
strated by the finding that mice deficient in the autophagy
genes Atg5 or Atg7 die soon after birth during the critical
starvation period when the transplacental nutrient supply
is interrupted (Komatsu et al., 2005; Kuma et al., 2004).
Recently, a fusion protein of GFP with the autophagy
protein LC3, the mammalian homolog of the yeast Atg8
gene, has been introduced as a specific marker for auto-
phagosomes (Mizushima et al., 2004). Food deprivation
was found to induce the rapid appearance of cytoplasmic
fluorescent dots, corresponding to autophagosomes, in
fast skeletal muscle of transgenic mice expressing GFP-
LC3 (Mizushima et al., 2004). In different cell systems,
autophagy is activated by depletion of nutrients or lack
of growth factors and, according to current views, this is
mediated by the kinase mTOR (Lum et al., 2005). Autoph-
agy is suppressed by mTOR, which is in turn controlled
directly by the level of intracellular amino acids and indi-
rectly by growth factors via Akt/PKB and cell energy status
via AMPK. Accordingly, rapamycin, a specific inhibitor of
mTOR, activates autophagy. However, autophagy can
also be induced by mTOR-independent mechanisms: leu-
cine starvation has been reported to induce mTOR-inde-
pendent autophagy in cultured myotubes (Mordier et al.,
2000), and mTOR has also been found to be dispensable
in other cell systems (Kochl et al., 2006; Sarkar et al., 2007;
Yamamoto et al., 2006).
Upregulation of autophagy and lysosomal genes has
been documented at the transcript and protein level in dif-
ferent settings, but the mechanisms controlling this tran-
scriptional regulation and their physiological relevance
have not been characterized. The lysosomal proteinase
cathepsin L is induced in muscle wasting (Sacheck et al.,
2007), and microarray analyses suggest that this is also
true for the autophagy-related genes LC3 and Gabarapl1
(Lecker et al., 2004). Several studies point to upregulation
of autophagy genes in other cell systems and in different
experimental conditions (Juhasz et al., 2007). However,
the factors involved in the transcriptional regulation of
autophagy genes have not yet been identified.
To characterize the mechanisms that control the auto-
phagic/lysosomal pathway during muscle atrophy in vivo,
we first identified autophagy-related genes induced in
atrophying muscle and determined whether the Akt-
mTOR pathway is involved in the upregulation of some of
these genes. Having found that Akt is essential but mTOR
is dispensable in suppressing autophagy, we tested the
hypothesis that FoxO transcription factors, which play
a major role in the activation of the ubiquitin-proteasome
system, are also involved in the activation of the autopha-
gic/lysosomal pathway. Gain- and loss-of-function exper-
iments strongly supported a major role of FoxO3, and two
targets and mediators of FoxO3, LC3 and Bnip3, were
identified. Finally, we addressed the question of whether
the induction of autophagy by FoxO3 is secondary to the
activation of the ubiquitin-proteasome system and found
that the two protein degradation pathways are indepen-
dently controlled by FoxO3.Cell MeRESULTS
Autophagy-Related Genes and Genes Involved
in the Regulation of Autophagy Are Induced
during Muscle Atrophy
The key ubiquitin ligases atrogin-1 andMuRF1 and several
other genes of the ubiquitin-proteasome system are upre-
gulated in different models of muscle wasting (Bodine
et al., 2001a; Sacheck et al., 2007). We asked whether
the induction of atrophy in skeletal muscle is also accom-
panied by the upregulation of autophagy-related genes.
As shown in Figure 1, 1 day of fasting induces the tran-
scription of several autophagy-related genes, including
two members of the Atg8 family, LC3 and Gabarapl1, as
well as Atg4b and some genes involved in the regulation
of autophagy, including Vps34 (a class III PI3K), Bnip3,
and Bnip3l. Similar changes were observed after 3-day
denervation; in this case, two additional autophagy-re-
lated genes, Beclin1 and Atg12, were found to be induced
(see Figure S1 in the Supplemental Data available with
this article online). In agreement with previous studies (Sa-
check et al., 2007), fasting and denervation also induced
the lysosomal proteinase cathepsin L (data not shown).
Thus, two different models of muscle atrophy led to in-
creased expression of different genes of the autophagic/
lysosomal pathway or genes involved in the regulation of
autophagy. Interestingly, four of the most upregulated
genes in these models, LC3, Gabarapl1, Bnip3, and
Bnip3l, are among the atrophy-related genes (‘‘atro-
genes’’) induced in other types of muscle wasting (Lecker
et al., 2004).
Autophagy-Related Gene Induction and
Autophagosome Formation Are Suppressed by Akt
To identify the signaling pathways responsible for the up-
regulation of autophagy-related genes, we focused on the
role of Akt/PKB, since activation of Akt by growth factors
is known to inhibit autophagy in different cell types (Lum
et al., 2005). In skeletal muscle, Akt promotes muscle
growth by inducing protein synthesis via mTOR (Bodine
et al., 2001b; Pallafacchina et al., 2002) and preventsmus-
cle wasting by blocking proteasome protein breakdown
through inhibition of FoxO transcription factors (Sandri
et al., 2004). To assess the effect of Akt activation on au-
tophagy, we generated a transgenic mouse line in which
an Akt-estrogen receptor (Akt-ER) fusion protein can be
activated in an inducible manner by tamoxifen specifically
in skeletal muscle (Figure S2). In control mice, 1 day of
fasting caused dephosphorylation of Akt. In contrast,
tamoxifen injection caused Akt-ER phosphorylation, as
well as phosphorylation of different Akt targets, including
FoxOs and the mTOR effectors 4E-BP1 and S6, even dur-
ing fasting (Figure 1B). Adult skeletal muscles were trans-
fected with the GFP-LC3 plasmid to monitor autophago-
some formation. In agreement with a previous report
(Mizushima et al., 2004), GFP-LC3-positive vesicles were
rare in adult muscle of fed mice but increased significantly
during fasting (Figure 1C; Figure S3). It has been reported
that LC3-positive dots sometimes represent proteintabolism 6, 458–471, December 2007 ª2007 Elsevier Inc. 459
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FoxO3 in AutophagyFigure 1. Regulation of AutophagyGenes andAutophagosome Formation in SkeletalMuscle Is Dependent on Akt but Independent
of mTOR
(A) Upregulation of autophagy genes in adult tibialis anterior muscle induced by 1 day of fasting. Quantitative PCR analysis was performed in triplicate
using specific oligonucleotides (see Table S1). The differences in gene expression levels in control versus fasted animals were statistically significant
(*p < 0.001) except for Atg12 and beclin1. Error bars represent SD.
(B) Immunoblotting analysis shows that Akt activation induced by tamoxifen in extensor digitorum longus muscles from Akt transgenic mice
(described in Figure S2) causes phosphorylation of the Akt targets 4E-BP1, FoxO1, FoxO3, and S6 in muscles from both fed and starved mice.
(C) Autophagosome formation induced by fasting is suppressed by tamoxifen-inducible activated Akt. Adult muscles from Akt transgenic mice were
transfected by electroporation with a plasmid expressing GFP-LC3. Eight days later, mice were treated with tamoxifen or vehicle and fasted for 24 hr
before sacrifice. Myofibers expressing GFP-LC3 were analyzed by fluorescence microscopy. Autophagosomes were quantified by counting
GFP-LC3-positive dots and normalizing for cross-sectional area. Values represent means of four different experiments; error bars represent SEM.
*p < 0.001.
(D) Immunoblotting for LC3 shows that the amount of LC3-I (upper band) is decreased and conversion of LC3-I to LC3-II is induced in starvedmuscles
(upper panel). LC3 lipidation is blocked by tamoxifen treatment (lower panel).
(E) Akt blocks the induction of LC3, Gabarapl1, Bnip3, Bnip3l, cathepsin L, and atrogin-1 transcripts by fasting, and this effect is not reversed by
rapamycin treatment. Error bars represent SD.460 Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevier Inc.
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FoxO3 in Autophagyaggregation rather than autophagy (Kuma et al., 2007).
However, we did not observe such structures in muscles
from fed animals, even in highly transfected muscle fibers
(Figure 1C; Figure S3). Overexpression of activated Akt
in fasting muscle completely abolished the formation of
GFP-LC3-positive autophagosomes (Figure1C;FigureS4)
and the conversion of LC3 from the unlipidated species
(LC3-I) to the lipidated species (LC3-II) (Figure 1D). Fur-
thermore, Akt prevented the increase in transcript levels
of LC3, Gabarapl1, Bnip3, Bnip3l, cathepsin L, and atro-
gin-1 induced by fasting (Figure 1E) or denervation (Fig-
ure S5). These results support the conclusion that Akt
has a major role in the transcriptional control of the
autophagy program in skeletal muscle in vivo and raise
the question of which downstream pathways mediate
the effect of Akt. To address this issue, we first
examined the role of a major Akt effector, the kinase
mTOR, which is known to suppress autophagy in different
cell systems.
Autophagy-Related Genes and Autophagic
Vesicles Are Not Induced by Rapamycin in Skeletal
Muscle
To determine whether the repressive effect of Akt on the
fasting-dependentupregulationofautophagy-relatedgenes
is mediated by mTOR, we examined the effect of the
mTOR inhibitor rapamycin on these genes’ expression. As
shown in Figure 1E, rapamycin did not reverse the effect
of Akt on autophagy-related genes or on cathepsin L and
atrogin-1 gene expression. Accordingly, rapamycin did
not induce autophagosome formation in Akt transgenic
mice or control mice (Figure 2A). In our system, rapamycin
caused complete dephosphorylation of S6K and S6, as
well as 4E-BP1, confirming efficient mTOR inhibition (Fig-
ure 2B). Moreover, rapamycin induced LC3 lipidation in
liver, but not in skeletal muscle (Figure S6). To confirm
the rapamycin results, we transfected adult muscles with
vectors producing shRNAs specific for mTOR. Two differ-
ent shRNAs effectively knocked down mTOR expression
(Figure 2C) and caused dephosphorylation of S6, without
altering the level of Akt phosphorylation, in transfected
muscle fibers ofAkt transgenicmice (Figure 2D; FigureS7).
However, autophagosome formation was not induced
by RNAi-mediated knockdown of mTOR (Figure 2E; Fig-
ure S7), thus confirming the results with rapamycin.
mTOR Controls Autophagy via the mTORC2
Complex
The mTOR kinase is part of two signaling complexes, re-
ferred to as mTOR complex 1 (mTORC1), which is rapa-
mycin sensitive and contains raptor, and mTOR complex
2 (mTORC2), which is rapamycin insensitive and contains
rictor. Inactivation of mTORC2 induced by rictor knockout
has revealed that mTORC2 is required for signaling to
Akt-FoxO but not to S6K1, which is a target of mTORC1
(Guertin et al., 2006). To explore the role of the mTORC2
pathway in skeletal muscle, we used two plasmid vectors
producing shRNAs specific for rictor. Both shRNAs
knocked down rictor expression (Figure 2F) and, whenCell Mecotransfected in vivo with plasmids coding for FoxO3, in-
duced FoxO3 nuclear translocation in transfected myofib-
ers, supporting the notion that mTORC2 affects FoxO
signaling (Figure 2G). Accordingly, we observed that
RNAi-mediated knockdown of rictor induced a significant
increase in autophagosome formation in skeletal muscle
(Figure 2H) and that this effect was abrogated by constitu-
tively active Akt (ca-Akt) in both the absence (Figure S8)
and the presence of rapamycin (Figure 2I). Taken together,
these results indicate that fasting-induced autophago-
some formation and autophagy-gene upregulation are
independent of mTORC1 but partially dependent on
mTORC2 and suggest that the Akt-FoxO pathway may be
involved in the control of autophagy.
FoxO3 Induces Autophagy and Lysosomal Protein
Breakdown in Muscle Fibers
To directly determine the role of FoxO transcription factors
in autophagy, we first examined the effect of constitutively
active FoxO3 (ca-FoxO3) on autophagosome formation,
as we had previously shown that ca-FoxO3 causes dra-
matic muscle atrophy in vivo (Sandri et al., 2004). Cotrans-
fection with ca-FoxO3 and GFP-LC3 was found to induce
a large number of fluorescent puncta in single cultured
fibers isolated from adult skeletal muscle, in myofibers of
fed live mice as shown by two-photon microscopy, and in
muscle sections (Figures 3A–3C). Induction of autophagy
by ca-FoxO3 was confirmed by electron microscopy of
muscles cotransfectedwith ca-FoxO3 andGFP. By apply-
ing a fixation-embedding procedure that allows preserva-
tion of GFP fluorescence, we found that transfected fibers
were filled with autophagic vacuoles (Figure 3D). Atrophic
muscle fibers containing accumulations of large autopha-
gosomes were also seen frequently in transfected mus-
cles processed by conventional fixation-embedding pro-
cedures (Figure 3E), whereas they were not observed in
control muscles transfected with GFP plasmids (data not
shown). The notion that FoxO3 activates the autophagic/
lysosomal system in skeletal muscle cells is supported
by studies on cultured C2C12 muscle cells showing that
FoxO3 overexpression markedly increases LC3 lipidation
(Figure 3F) and that a major fraction (about 70%) of the
protein breakdown induced by FoxO3 is lysosomal
dependent because it is blocked by concanamycin A,
a specific inhibitor of the lysosomal proton pump (Fig-
ure 3G).
FoxO3 Is Required for Fasting-Induced Autophagy
To determine whether FoxO3 is required for the induction
of autophagy by fasting, we used a dominant-negative
FoxO3 mutant (dn-FoxO3) that was previously found to
prevent the upregulation of atrogin-1 andmuscle cell atro-
phy induced by dexamethasone (Sandri et al., 2004). As
shown in Figure 4A, dn-FoxO3 markedly inhibits autopha-
gosome formation induced by fasting in adult skeletal
muscle. Similar results were obtained using two different
siRNA sequences against FoxO3 (Figure 4B). The result
of the RNAi experiments was validated by a rescue exper-
iment in which we used a human FoxO3 cDNA. There aretabolism 6, 458–471, December 2007 ª2007 Elsevier Inc. 461
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FoxO3 in AutophagyFigure 2. mTOR Regulates Autophagy via the mTORC2 Complex
(A) Autophagosome formation is not induced by rapamycin in skeletal muscle. Muscles from Akt transgenic mice (AKT-ER) (upper panel) and wild-
type mice (lower panel) were transfected with GFP-LC3, and 7 days later, mice were treated with rapamycin for 4 days as described in Experimental
Procedures. Fluorescent autophagosomal vesicles were counted as in Figure 1C.
(B) Rapamycin causes suppression of mTOR activity in Akt transgenic mice (upper panel) and control mice (lower panel) as shown by complete
dephosphorylation of the Akt targets S6K, S6, and 4E-BP1.
(C) RNAi-mediated knockdown of mTOR revealed by immunoblotting. Murine embryonic fibroblasts (MEFs) were transfected with vectors expressing
four different mTOR shRNAs.
(D) Immunostaining for anti-phospho-S6 shows that the mTOR downstream target S6 is dephosphorylated in muscle fibers in which mTOR is
knocked down. Skeletal muscles of adult Akt transgenic mice were cotransfected with YFP-LC3 and mTOR shRNAs 2 and 3.
(E) Autophagosome formation is not induced bymTOR knockdown. Adult skeletal muscles were transfected with YFP-LC3 andmTOR shRNAs 2 or 3.
Vesicles were counted as in Figure 1C.462 Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevier Inc.
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FoxO3 in Autophagythree mismatches between the mouse FoxO3(2) siRNA
sequence and the corresponding human sequence; there-
fore, human FoxO3 should not be silenced by the mouse
siRNA. In fact, cotransfection of human FoxO3 cDNA
restored autophagy in muscle fibers in which mouse
FoxO3 was knocked down (Figure 4C). Since FoxO1 has
been reported to inhibit mTOR signaling in skeletal muscle
(Southgate et al., 2007), we explored whether the same is
true for FoxO3. However, phosphorylation of S6 was not
affected by ca-FoxO3 or dn-FoxO3 (Figures S9 and S10).
FoxO3 Regulates LC3 Gene Expression
in Skeletal Muscle
Having shown that FoxO3 is necessary and sufficient for
the induction of autophagy, we asked whether FoxO3 is
directly involved in the transcriptional regulation of au-
tophagy-related genes and first focused on LC3, a typical
autophagy-related gene of the Atg8 family. We identified
three putative FoxO binding sites in the promoter region
of the LC3 gene. The ability of FoxO3 to bind to the most
proximal FoxO site in the LC3 promoter was tested by
chromatin immunoprecipitation (ChIP) assays in skeletal
muscle nuclei. Overexpressed ca-FoxO3 and endoge-
nous FoxO3 were found to interact with the LC3 promoter
(Figure 5A; Figure S11). Furthermore, fasting increased
FoxO3 binding and histone acetylation at this site. To de-
termine the functional role of FoxO3 binding, the region of
the LC3 promoter containing the proximal FoxO site was
cloned upstreamof aminimalSV40promoter into a lucifer-
ase reporter vector and used for in vivo transfection in
skeletal muscle. ca-FoxO3 activates the LC3 promoter
in transfected muscles, but not the promoter in which
the FoxO site was mutated (Figure 5B). In contrast, dn-
FoxO3 strongly inhibited the LC3 promoter (Figure 5C),
and FoxO3 inhibition by either dn-FoxO3 or RNAi de-
creased LC3 protein in transfected cells (Figure 5D). To
determine whether the transcriptional regulation of LC3
by FoxO3 is physiologically relevant, we cotransfected
skeletal muscles with ca-FoxO3 and LC3 shRNAs. Muscle
atrophy induced by ca-FoxO3 was significantly de-
creased, but not completely abolished, by LC3 knock-
down (Figure 5E).
FoxO3-Induced Autophagy Is Modulated by Bnip3
We subsequently focused on Bnip3 and Bnip3l, which are
among the most induced atrogenes in different types of
muscle wasting and have been shown to control autoph-
agy in other cell systems (Hamacher-Brady et al., 2007;
Tracy et al., 2007). We observed that several potentialCell Metbinding sites for FoxO transcription factors are present
in the Bnip3 and Bnip3l promoters and found that FoxO3
binding to Bnip3 and Bnip3l promoters increased in fast-
ing muscle as determined by ChIP experiments (Fig-
ure 6A). The notion that FoxO3may control the expression
of Bnip3 was strongly supported by the finding that ca-
FoxO3 induced Bnip3 and Bnip3l expression (Figure 6B).
Conversely, FoxO3 inhibition by dn-FoxO3 or shRNAs
reduced Bnip3 protein level (Figure 6C). Importantly, over-
expression of Bnip3 or Bnip3l was sufficient to induce
autophagosome formation in normal skeletal muscle
(Figure 6D). Next, we examined whether Bnip3, which is
strongly upregulated in fasting muscle, is required for
the induction of the autophagy process. Two siRNA se-
quences, one of which is shown in Figure 6E and the other
of which was reported in a previous study (Hamacher-
Brady et al., 2007), were used in these experiments.
Bnip3 knockdown strongly reduced both the formation
of GFP-LC3-positive autophagosomes and LC3 lipidation
(Figures 6F and 6G) induced by ca-FoxO3 in skeletal mus-
cle. In addition, autophagosome formation induced by
fasting was also markedly reduced, though not com-
pletely abolished, by Bnip3 knockdown (Figure 6H).
Thus, Bnip3 induction by FoxO3 appears to play a major
role in autophagosome formation during muscle atrophy.
Autophagy Is Not Impaired by Inhibition
of the Ubiquitin-Proteasome System
FoxO transcription factors are known to control the ex-
pression of the ubiquitin ligases atrogin-1 and MuRF1
and the activation of the ubiquitin-proteasome system,
a major pathway involved in muscle protein degradation
and muscle atrophy (Stitt et al., 2004). We therefore asked
whether the induction of autophagy by FoxO3 is due to
a direct effect or is secondary to the activation of the ubiq-
uitin-proteasomal pathway. To determine whether au-
tophagy is dependent on the activity of the muscle-spe-
cific ubiquitin ligases, skeletal muscles of atrogin-1
and MuRF1 knockout mice were transfected with GFP-
LC3, and 7 days later, the mice were fasted for 24 hr. As
shown in Figures 7A and 7B, autophagosome formation
was unaffected by loss of these genes. To determine
whether autophagy is dependent on proteasome function,
we used the proteasome inhibitor MG262. The induction
of GFP-LC3-positive autophagosomes by ca-FoxO3
was unaffected by treatment with MG262 (Figure 7C). To
demonstrate the efficacy of MG262 treatment in blocking
proteasome function in vivo, skeletal muscles of control
and MG262-treated mice were transfected with the(F) RNAi-mediated knockdown of rictor revealed by immunoblotting. MEFs were transfected with vectors expressing two different shRNAs against
rictor.
(G) Anti-HA immunostaining shows that FoxO3 is dephosphorylated and is translocated into the nucleus of myofibers of adult muscles transfected
with wild-type HA-FoxO3 and pSUPER vectors expressing shRNAs against rictor.
(H) Knockdownof rictor activates autophagy inmice. Adult skeletal muscles were cotransfectedwith YFP-LC3 and shRNAs against rictor. Seven days
later, YFP-positive vesicles were quantified. *p < 0.001.
(I) Overexpression of constitutively active Akt (ca-Akt) blocks autophagosome formation induced by mTORC2 inhibition. Skeletal muscles of adult
transgenic mice were cotransfected with YFP-LC3 and RNAi vectors against rictor. Mice were treated with tamoxifen and with rapamycin as
described in Figure 1D.
Error bars represent SEM.abolism 6, 458–471, December 2007 ª2007 Elsevier Inc. 463
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FoxO3 in AutophagyFigure 3. Autophagosome Formation Is Induced in Adult Skeletal Muscle by Constitutively Active FoxO3
(A) Isolated single myofibers were transfected with GFP-LC3 and either constitutively active FoxO3 (ca-FoxO3) or mock vector and placed in cell
culture. Forty-eight hours later, GFP-positive fibers were analyzed for autophagosome formation by confocal microscopy.
(B) Imaging of FoxO3-mediated autophagosome formation in muscles of live mice. Adult tibialis anterior muscle was transfected with GFP-LC3 and
either ca-FoxO3 or mock vector. Two weeks later, muscle was exposed and observed in situ using two-photon microscopy as described in Exper-
imental Procedures.
(C) Adult muscles were transfected with GFP-LC3 and either ca-FoxO3 or mock vector (control). Two weeks later, muscles were collected and
analyzed for fluorescent vesicle formation.
(D) Electron micrographs of ca-FoxO3-transfected fibers. Adult muscles were cotransfected with GFP and ca-FoxO3. Atrophic GFP-positive fibers
identified in the semithin section (upper left panel) show numerous autophagosomes when analyzed by electron microscopy (upper right and lower
panels).
(E) Electron micrograph from a muscle transfected with ca-FoxO3 processed using standard fixation-embedding procedures. Note the large auto-
phagosomes in an atrophic myofiber. The boxed area in the left panel is shown at higher magnification in the right panel.
(F) C2C12 myotubes were infected with control or ca-FoxO3 adenoviruses. Twenty-four hours later, cells were treated with concanamycin A (0.1 mM)
to prevent LC3-II degradation. FoxO3 induces an increase in conversion of LC3-I to LC3-II (upper panel). Quantification of the LC3 conversion ratio
(LC3-II/LC3-I) is shown in the lower panel.
(G) ca-FoxO3 increases lysosomal proteolysis in C2C12 cells, and this increase is almost completely abolished by the lysosomal inhibitor concana-
mycin A. *p < 0.001. Error bars represent SEM.464 Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevier Inc.
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FoxO3 in AutophagyFigure 4. Fasting-Induced Autophagy Is Blocked by Dominant-Negative FoxO3 and by RNAi-Mediated FoxO3 Knockdown
(A) Autophagosome formation induced by fasting is blocked by dominant-negative FoxO3 (dn-FoxO3). Adult muscles were cotransfected with GFP-
LC3 and dn-FoxO3 or control vector, and GFP-positive vesicles were quantified. *p < 0.001.
(B) RNAi-mediated knockdown of FoxO3 inhibits autophagosome formation during fasting. Upper panel: immunoblotting analyses confirmed that
pSUPER vectors expressing shRNA against FoxO3 were effective in blocking FoxO3 but not FoxO1. Lower panel: adult muscles were transfected
with YFP-LC3 together with control shRNA or two different FoxO3-specific shRNAs. One week later, mice were fasted for 24 hr, and fluorescent
vesicles were quantified as in Figure 1C. *p < 0.001.
(C) Inhibition of autophagosome formation induced by FoxO3 RNAi is rescued by overexpression of human FoxO3. Adult skeletal muscles were
cotransfected with YFP-LC3, wild-type human FoxO3, and a shRNA specific for mouse FoxO3. Seven days later, mice were fasted for 24 hr. Vesicle
formation is detected only in a myofiber positive for FoxO3 (asterisk). Anti-FoxO3 immunofluorescence confirms FoxO3 nuclear translocation during
fasting (arrow). Quantification of rescued fibers (shown at right) was performed as described above. *p < 0.001.
Error bars represent SEM.short-lived UbG76V-GFP reporter, using cotransfection
with histone 2B-RFP to identify transfected fibers (Linds-
ten et al., 2003). As shown in Figure 7D, GFP fluorescence
was detected in transfected fibers of MG262-treated
mice, but not in transfected fibers of control mice, thus
confirming that proteasome function is effectively re-
pressed by the inhibitor in vivo. These findings indicate
that FoxO3 controls the ubiquitin-proteasomal and auto-
phagic/lysosomal pathways independently.
DISCUSSION
Autophagy is a fundamental mechanism essential for cell
survival in all eukaryotic organisms. Cultured mammalian
cells die rapidly if autophagy is inhibited following nutrient
deprivation or growth-factor withdrawal (Lum et al., 2005),
and mice deficient in the Atg5 or Atg7 autophagy genes
do not survive the early neonatal starvation period (Ko-
matsu et al., 2005; Kuma et al., 2004). However, themech-
anisms responsible for the induction and regulation of the
autophagy program are poorly understood. In particular,Cell Malthough there is evidence that autophagy genes are upre-
gulated during the activation of the autophagic/lysosomal
pathway in different species (see Introduction), the tran-
scription factors responsible for the induction of these
genes are unknown. The present study, based primarily on
in vivo analyses in skeletal muscle, identifies a FoxO3-
Bnip3 pathway as amajor player in the transcriptional reg-
ulation of autophagy-related genes. The starting point of
this investigation was the demonstration that several
autophagy-related genes and genes involved in the regu-
lation of autophagy are upregulated in two models of
muscle atrophy, fasting and denervation.
The results presented here, based on gain- and loss-
of-function approaches, show that FoxO3 controls the
activation of the autophagic/lysosomal pathway during
muscle atrophy in vivo. This conclusion is supported by
studies in cultured muscle cells showing that FoxO3 stim-
ulates lysosomal proteolysis by inducing autophagy (Zhao
et al., 2007 [this issue of Cell Metabolism]). A role of FoxO
transcription factors in autophagy is also supported by
evidence from studies in C. elegans and Drosophila. Inetabolism 6, 458–471, December 2007 ª2007 Elsevier Inc. 465
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FoxO3 in AutophagyFigure 5. Upregulation of LC3 Is Under FoxO3 Control and Is Required for Muscle Wasting
(A) FoxO3 binds to a FoxO response element in the LC3 promoter as determined by ChIP, and this binding is increased in skeletal muscle by fasting.
(B) ca-FoxO3 activates an LC3 promoter-reporter construct, but not a construct in which the FoxO binding site is mutated. A plasmid coding for the
region of the LC3 promoter containing the proximal FoxO site or the mutated one linked to a minimal SV40 promoter and a luciferase reporter was
transfected into adult tibialis anterior muscle in the presence or absence of ca-FoxO3. A renilla luciferase construct was cotransfected to normalize for
transfection efficiency. Eight days later, firefly/renilla luciferase activity was determined. *p < 0.001. Error bars represent SD.
(C) The activity of the LC3 reporter is suppressed by dn-FoxO3. Experimental conditions were as in (B). Error bars represent SD.
(D) FoxO3 inhibition by RNAi against FoxO3 or by dn-FoxO3 reduces LC3 protein level. MEFs were transfected with either shRNA specific for mouse
FoxO3 or a vector expressing dn-FoxO3 and analyzed by immunoblotting against LC3 and FoxO3. Note that the signal with FoxO3 antibodies is
decreased by FoxO3 RNAi and increased by overexpression of dn-FoxO3.
(E) Muscle atrophy induced by FoxO3 is reduced by LC3 RNAi. Adult skeletal muscles were transfected with shRNA specific for mouse LC3 or GFP
with or without HA-tagged ca-FoxO3 and examined after 2 weeks. Cross-sectional area of transfected fibers, identified by anti-HA immunofluores-
cence, was measured as described previously (Sandri et al., 2004). *p < 0.001. Error bars represent SEM.response to nutrient deprivation, nematodes undergo da-
uer formation, a stage of development arrest, and autoph-
agy genes are essential for dauer formation, which is con-
trolled positively by daf-16 (the C. elegans homolog of
FoxO) and negatively by Akt (Melendez et al., 2003). Ac-
cordingly, a recent study has shown that flies that have
mutated DFoxO cannot activate autophagy in response
to starvation, while DFoxO overexpression is sufficient to
activate autophagy (Juhasz et al., 2007).
FoxO3 was previously shown to control the ubiquitin-
proteasome pathway by upregulating two crucial ubiquitin
ligases, atrogin-1 and MuRF1 (Sandri et al., 2004; Stitt
et al., 2004). We show here that the effect of FoxO3 on au-
tophagy is not affected by deficiency of these two genes466 Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevior by inhibition of proteasome function, suggesting that
FoxO3 controls the twomajor cellular catabolic pathways,
the ubiquitin-proteasomal pathway and the autophagic/
lysosomal pathway, independently. This interpretation is
consistent with the finding that proteasome function is
not affected by loss of autophagy in the brain (Komatsu
et al., 2006). On the other hand, protein breakdown via
the proteasome and lysosome is likely to proceed in a co-
ordinatedmanner in different models of muscle atrophy, in
which the degradation of myofibrillar proteins via the pro-
teasome proceeds in parallel with the disposal of mito-
chondria and sarcoplasmic reticulum membranes via the
autophagic/lysosomal pathway. This could well be ex-
plained by the existence of a common transcription factorer Inc.
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FoxO3 in AutophagyFigure 6. Bnip3 Genes Are Controlled by FoxO3 and Mediate the Effect of FoxO3 on Autophagy
(A) FoxO3 binding to a FoxO response element in the Bnip3l and Bnip3 promoters, as determined by ChIP, is increased by fasting.
(B) ca-FoxO3 induces Bnip3 and Bnip3l protein expression in HEK293 cells as determined by western blotting.
(C) FoxO3 inhibition by RNAi or by d.nFoxO3 reduces Bnip3 protein detected by immunoblotting.
(D) Bnip3 and Bnip3l induce the formation of autophagic vesicles in skeletal muscle. Adult muscles were cotransfected with GFP-LC3 and Bnip3 or
Bnip3l expression plasmids, and LC3-positive vesicles were quantified as in Figure 1C. *p < 0.001.
(E) Immunoblotting analysis shows reduced Bnip3 protein levels after transfection of MEFs with a pSUPER vector expressing shRNA against Bnip3.
(F) Bnip3 inhibition by RNAi blocks FoxO3-mediated autophagosome formation. Adult skeletal muscles were cotransfected with vectors expressing
YFP-LC3, ca-FoxO3, and shRNAs against Bnip3, and YFP-positive vesicles were quantified. *p < 0.001; #p < 0.001.
(G) Conversion of LC3-I to LC3-II induced by ca-FoxO3 is prevented by RNAi against Bnip3 in MEFs.
(H) RNAi-mediated knockdown of Bnip3 inhibits autophagosome formation during fasting. Adult skeletal muscles were cotransfected with YFP-LC3
and vectors expressing shRNA against Bnip3. Seven days later, mice were fasted for 24 hr and YFP-positive vesicles were quantified. *p < 0.001;
#p < 0.001.
Error bars represent SEM.Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevier Inc. 467
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FoxO3 in AutophagyFigure 7. Autophagosome Formation Is Not Impaired by Loss ofMuscle-Specific Ubiquitin Ligases or Blockade of the Proteasome
(A and B) Fasting-induced autophagy is not impaired in adult skeletal muscle of atrogin-1 null (A) orMuRF1 null (B) mice. Mice were transfected with
GFP-LC3. Seven days later, mice were fasted for 24 hr and GFP-positive vesicles were quantified. *p < 0.001.
(C) FoxO3-induced autophagosome formation is not impaired by proteasome inhibition withMG262.Muscles of wild-typemice were transfected with
GFP-LC3 and ca-FoxO3. MG262 was injected daily for the last 4 days before sacrifice, and GFP-positive vesicles were counted. *p < 0.001.
(D) Validation of the efficacy of the proteasome inhibitor MG262. Adult skeletal muscles were cotransfected with histone 2B-RFP and UbG76V-GFP.
Transfected myofibers are revealed by the presence of red nuclei. The mutated ubiquitin is targeted to proteasomal degradation, and the GFP
fluorescence is not detected in transfected myofibers but is revealed when proteasome function is inhibited by MG262 treatment.
Error bars represent SEM.that orchestratesmuscle atrophy by controlling both path-
ways, although other possible mechanisms of interaction
between the two pathways remain to be established.
Autophagy is a fundamental mechanism of survival during
starvation, and the results reported here support a role of
FoxO factors as master regulators of the transcriptional
adaptations of the organism to starvation. In fact, the in-
creased muscle protein catabolism induced by FoxO3
contributes amino acids that are used for glucose pro-
duction by the liver, where FoxO1 has been shown to con-
trol gluconeogenesis gene expression (Puigserver et al.,
2003).
A surprising finding of this study is that mTOR does not
appear to play a significant role in the activation of the au-
tophagic/lysosomal pathway during muscle atrophy. Pre-
vious studies have shown that themTOR inhibitor rapamy-
cin inducesautophagy inmanycell types (Lumet al., 2005).
However, mTOR-independent autophagy has also been
reported in different cell systems, including cultured mus-
cle cells (Kochl et al., 2006; Mordier et al., 2000; Sarkar
et al., 2007; Yamamoto et al., 2006).We found that autoph-
agy is unaffected in skeletal muscle whenmTOR activity is
blockedby rapamycin orbymTORknockdown, conditions
in which S6 phosphorylation is completely blocked. Fur-
thermore, rapamycin was not able to reverse the inhibitory
effect of activated Akt in preventing the upregulation of au-
tophagy-related genes inducedby fasting.mTOR is part of
two multiprotein complexes: mTORC1, which contains468 Cell Metabolism 6, 458–471, December 2007 ª2007 Elsevraptor and is rapamycin sensitive, is required for signaling
to S6K and 4E-BP1, while mTORC2, which contains rictor,
is required for signaling to Akt-FoxO (Guertin et al., 2006).
Our finding that mTORC2 inhibition by RNAi against rictor
results in FoxO3 translocation and autophagy induction is
consistent with the role of FoxO. The finding that autoph-
agy can be induced by rictor knockdown but not by
mTOR knockdown could be explained by the existence
of a negative feedback effect of S6KonAkt activity (Aguilar
et al., 2007). Thus, the two mTOR complexes may have
opposite effects on Akt activity.
An additional factor that complicates the interpretation
of the effect of rapamycin is that long-term rapamycin
treatment in vitro can also inhibit the mTORC2 complex
in some cell types and thus potentially affect the Akt-
FoxO pathway (Sarbassov et al., 2006). This raises the
possibility that, under certain circumstances, rapamycin
may induce autophagy not through a direct effect—e.g.,
by blocking mTOR phosphorylation of specific compo-
nents of the autophagy machinery—but through an indi-
rect transcriptional effect by inhibiting Akt and thus
derepressing FoxO. However, in our in vivo system,
rapamycin treatment did not affect Akt phosphorylation
(Figure 2B) but blocked mTORC1, as revealed by S6K
and S6 dephosphorylation. The discrepancy between
the results presented here and previous studies with
respect to the role of mTOR in autophagy might also re-
flect the slower pace of autophagy in vivo, based onier Inc.
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FoxO3 in Autophagytranscription-dependent regulation via FoxO3, compared
to the rapid pace of autophagy in some in vitro systems,
based on transcription-independent regulation via mTOR.
The complexity of the regulatory networks controlling
autophagy is also illustrated by the paradoxical and still
unexplained finding that Vps34 has been suggested to
be a positive effector in both autophagy and mTORC1
signaling (Nobukuni et al., 2007).
The mechanism of FoxO3 effect on autophagy remains
to be determined; however, our results on the transcrip-
tional regulation of the autophagy-related gene LC3 and
the autophagy-regulatory genes Bnip3 and Bnip3l sug-
gest that FoxO3 could act in two ways. The upregulation
of LC3 is unlikely to be relevant to the induction of autoph-
agy but is likely to be important for the maintenance of this
process. In agreement with previous studies (Mizushima
et al., 2004), we found that autophagosome formation is
not induced by overexpression of GFP-LC3 in fed mice;
therefore, LC3 induction per se is not sufficient to trigger
autophagy. On the other hand, since LC3 is continuously
consumed during the activation of the autophagic/lyso-
somal pathway that occurs in muscle atrophy, it is likely
that the upregulation of LC3 is required to replenish the
LC3 protein pool and thus allow the progression of au-
tophagy. LC3 inhibition by RNAi partially blocks muscle
atrophy, confirming that autophagy contributes to muscle
atrophy and that upregulation of LC3 is physiologically im-
portant. In contrast, the upregulation of Bnip3 has a major
role inmediating the effect of FoxO3, as shown by the find-
ings that (1) the binding of FoxO3 to the Bnip3 and Bnip3l
promoters is increased in fasted muscle, (2) autophago-
some formation is induced in normal muscle in vivo by
Bnip3 or Bnip3l overexpression, and (3) the induction of
autophagy by ca-FoxO3 is markedly decreased by Bnip3
knockdown. The fact that autophagosome formation is
not completely abolished by Bnip3 RNAi could be due to
the presence of Bnip3l. Bnip3 is a Bcl-2-related BH3-only
protein that is induced by hypoxia in cultured cardiomyo-
cytes (Kubasiak et al., 2002) and ischemic regions of tu-
mors (Okami et al., 2004) and was initially implicated in
cell death. However, Bnip3 is now emerging as a central
player inautophagysignaling.Bnip3 inhibitionusingadom-
inant-negative Bnip3 mutant blocks autophagy in cardio-
myocytes during ischemia-reperfusion injury (Hamacher-
Brady et al., 2007), and knockdown of Bnip3 blocks
autophagy in hypoxic tumor cells (Tracy et al., 2007). Con-
versely, overexpression of Bnip3 increases autophagy in
these same cell systems (Hamacher-Brady et al., 2007;
Tracy et al., 2007). In agreement with the results presented
here, Bnip3l has been shown to be under the control of
FoxO3 in breast cancer cell lines (Real et al., 2005).
In conclusion, our results point to a FoxO3-Bnip3 path-
way as a major regulatory pathway of autophagy in skele-
tal muscle in vivo. Since autophagy is implicated in a vari-
ety of pathological processes, a better understanding of
the regulatory role of FoxO3 and Bnip3 in autophagy in dif-
ferent cell systems will be important for the treatment of
not onlymusclewasting disorders but also other diseases,
including cancer and neurodegenerative diseases.Cell MEXPERIMENTAL PROCEDURES
Animals and In Vivo Transfection Experiments
Experiments were performed on adult CD1 mice. The inducible trans-
genic mice are described in Figure S2. In vivo transfection experiments
were performed as described previously (Sandri et al., 2004). In some
experiments, mice were injected intraperitoneally (i.p.) with 4 mg/kg
rapamycin as described previously (Pallafacchina et al., 2002). Mice
transfected with the UbG76V-GFP reporter were treated for 4 days
with a daily i.p. injection of 150 ml of MG262 (5 mmol/kg) or vehicle
only (30% DMSO in 0.9% NaCl).
Plasmids and Antibodies
See Supplemental Experimental Procedures.
Gene Expression Analyses
Total RNA was prepared from skeletal muscle using the Promega SV
Total RNA Isolation kit. Complementary DNA generatedwith Invitrogen
SuperScript III reverse transcriptase was analyzed by quantitative real-
time RT-PCR using the QIAGEN QuantiTect SYBR Green PCR kit. All
data were normalized to b-actin or GAPDH expression. Oligonucleo-
tide primers used are listed in Table S1.
Immunoblotting
Frozen skeletal muscle was pulverized by pestle and mortar, lysed,
and immunoblotted as described previously (Sandri et al., 2004). Blots
were stripped using Restore western blotting stripping buffer (Pierce)
and reprobed if necessary. Antibodies used are listed in Supplemental
Experimental Procedures.
Fluorescence Microscopy and Electron Microscopy
Cryosections of muscle transfected with GFP-LC3 were examined
using a fluorescence microscope, and fluorescent dots were counted
as described previously, normalizing for cross-sectional area (Mizush-
ima et al., 2004). For electron microscopy, we used both conventional
fixation-embedding procedures and another procedure based on
fixation in paraformaldehyde-glutaraldehyde without osmium and em-
bedding in LR White resin, which allows preservation of GFP fluores-
cence in semithin 1 mm sections and subsequent analysis of serial
thin sections by electron microscopy (Luby-Phelps et al., 2003).
In Vivo Imaging via Two-Photon Microscopy
Tomonitor autophagosome formation in situ in living animals, muscles
were transfected with GFP-LC3 probe, and two-photon microscopy
was performed 2weeks later upon in situ exposure of transfectedmus-
cles as described previously (Tothova et al., 2006).
Single-Fiber Analyses
Flexor digitorum brevis muscles from adult mice were digested in type
I collagenase at 4C for 1 hr, at 37C for 2 hr, and dissociated into sin-
gle fibers. The fibers were electroporated using a BTX porator (50
volts/4 mm, 3 pulses, 200 ms intervals) to transfer plasmid DNA and
then plated on glass coverslips coated with laminin and cultured in
Tyrode’s salt solution (pH 7.3) containing 10% fetal bovine serum,
50 U/ml penicillin, 50 mg/ml streptomycin, and 5% CO2 (37
C).
Protein Breakdown Assay
C2C12 myotubes were incubated with [3H]tyrosine 24 hr before infec-
tion and then infected with control or ca-FoxO3 virus for 24 hr. After the
chase period, new medium containing concanamycin A (0.1 mM) was
added, and proteolysis was measured starting 1 hr later (Sacheck
et al., 2004). Each point is the average of four plates.
In Vivo RNAi
In vivo RNAi experiments were performed as described previously
(Sandri et al., 2004) using at least two difference sequences for each
gene. Sequences and plasmids used are listed in Supplemental Exper-
imental Procedures and Table S2. For the validation of shRNAetabolism 6, 458–471, December 2007 ª2007 Elsevier Inc. 469
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FoxO3 in Autophagyconstructs, murine embryonic fibroblasts (MEFs) were maintained in
DMEM/10% FBS and transfected with shRNA constructs using Lipo-
fectamine 2000 (Invitrogen). Cells were lysed 72 hr later, and immuno-
blotting was performed as described above.
ChIP Assays and Promoter Analyses
We performed ChIP assays on adult skeletal muscle using the Chro-
matin Immunoprecipitation (ChIP) assay kit (Upstate). Oligonucleotide
primers used are listed in Table S3. The LC3mouse genomic DNA frag-
ment (1608 to 1379) was amplified by PCR with the same primers
and inserted into the KpnI and XhoI sites of pGL3-Promoter vector
(Promega). Mutations in the FoxO binding site were generated by
PCR using the QuikChange technique (Stratagene) with the primers
listed in Table S3. These constructs were transfected into tibialis ante-
rior muscles together with a renilla luciferase vector (pRLTK) to normal-
ize for transfection efficiency as described previously (Sandri et al.,
2004).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
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